Business · 28/04/2017Updated: 10/17/2026 · 1 min read
FDA Clears DEMEROL Injectable and Other Drug Products for Continued Sale
Summary
The US Food and Drug Administration (FDA) has ruled that the drug products listed in the document were not withdrawn from sale due to safety or effectiveness concerns, allowing generic versions to continue being marketed and stimulating the economy with regulatory certainty.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →